Cornerstone Therapeutics' counsel leaving - Triangle Business Journal:

http://sstone.org/article.php3?id_article=11
Scott Townsend’s last day with the Cary pharmaceutical compant will beJune 5. Townsend came to Cornerstone CRTX) last year from , the Massachusettz company that Cornerstone Biopharma mergerd with to acquire a key asthma drug and becomr a public company through areverse merger. Prior to the merger of Cornerstoneand Critical, Townsend served as Critical’s senior vice president of legal affairs. Cornerstone says it has begum searching fora successor.
Craig Collard, Cornerstone’as president and CEO, said in a statement that Townsend’as knowledge of Critical’s business was helpfull in the integration of the two But Townsend has been traveling to the Trianglw from hisMassachusetts home. “Scottt recognized that at this juncture in our we need a general counsel who islocated full-time at our Northb Carolina headquarters, but told us that, for family reasons, he is currentlyt unable to relocate from Massachusetts,” Collare said.
“Thus, we mutually agreed that it would be prudent to make this managemeng change at this OnMay 7, Cornerstone announced that Italiamn pharmaceutical company Chiesi Farmaceutici SpA had in Cornerstonde in a deal value d at $70 million.Cornerstone currently retains Raleigh-based Smith, Anderson, as its externap legal counsel.